Skip to content
Screener

RxSight, Inc. RXST Q4 2025 Annual earnings

Reported February 25, 2026 · After market close

Revenue$32.6MBeat by $2.4M
EPS-$0.22Beat by $0.11
Revenue estimate$30.2M
EPS estimate-$0.33

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$27.2M
EPS estimate-$0.29

Financials

Q4 2025

Income statement

See full
Revenue$32.6M-18.9%
Gross profit$25.3M-12.2%
Operating income-$11.3M-31.4%
Net income-$9.2M-54.1%
EPS (diluted)-$0.22-46.7%

Balance sheet

See full
Cash & equivalents$19.9M+19.4%
Total debt$11.0M-10.2%
Total equity$275.7M-2.0%
Total assets$311.8M-2.1%

Cash flow

See full
Operating cash flow-$1.1M+73.8%
CapEx$1.1M+34.2%
Free cash flow-$2.3M+55.9%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$428.44M-69.1%
Enterprise value$419.53M-69.6%
P/S3.2×-6.7×

Profitability

See full
Gross margin76.6%+5.9pp
Operating margin-35.8%+20.2pp
Net margin-29%+26.3pp
FCF margin-14.4%-1.3pp

Returns & leverage

See full
Return on equity-14%+2.0pp
Debt / equity0×0.0×
Current ratio10.9×-0.4×

Segments

By product

See full
Rxlal$28.2M-1.2%
LDD$3.0M-72.2%
Service Warranty Service Contracts And Accessories$1.5M+43.5%

FAQ

When did RxSight, Inc. report Q4 2025 earnings?
RxSight, Inc. (RXST) reported Q4 2025 earnings on February 25, 2026 after market close.
What were RxSight, Inc.'s Q4 2025 revenue and EPS?
RxSight, Inc. reported revenue of $32.6M and eps of $-0.22 for Q4 2025.
Did RxSight, Inc. beat estimates in Q4 2025?
Revenue beat the consensus estimate of $30.2M by $2.4M. EPS beat the consensus estimate of $-0.33 by $0.11.
How did RxSight, Inc.'s Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 18.9% from $40.2M a year earlier.
Where can I find RxSight, Inc.'s Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-071516) and the 10-K periodic report (0001193125-26-071775) directly on SEC EDGAR. The filing index links above go to sec.gov.